Politics Helen Branswell STAT Plus: House GOP inquiry over gain-of-function research targets a scientific giant
Politics Brittany Trang STAT Plus: Doctors’ lobby doubles down on the fight against expanding open access to research
First Opinion Richard Joseph and Rachele Pojednic How to separate sound wellness solutions from seductive snake oil
Pharmalot Ed Silverman STAT Plus: Sanders wants NIH to adopt ‘reasonable pricing’ language for drugs that agency research helps develop
Politics Sarah Owermohle STAT Plus: Debt ceiling deal could mean cancer, disease research cuts, advocates warn
Politics Sarah Owermohle and Brittany Trang STAT Plus: New Biden science agency ARPA-H launches first program, targeting bone regrowth
Pharmalot Ed Silverman STAT Plus: NIH systems for non-human primate research fall short, threatening biomedical research
Politics Sarah Owermohle STAT Plus: Biden’s pick to lead NIH stares down an increasingly political litany of questions
Pharmalot Ed Silverman STAT Plus: Pharmalittle: White House to tap cancer center chief to lead NIH; generic abortion pill maker sues FDA
First Opinion Jordan Dworkin and Julian Elliott Strengthen science by funding living evidence synthesis
Pharmalot Ed Silverman STAT Plus: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug
Politics Sarah Owermohle STAT Plus: Biden makes big demands for cancer research and new ARPA-H agency
Politics Jim Puzzanghera — Boston Globe STAT Plus: Hugh Auchincloss was Anthony Fauci’s longtime deputy. Now he’s taking his job as House Republicans probe the pandemic
Politics Rachel Cohrs HHS needs better oversight of research that alters pathogens, government watchdog says
First Opinion Bonnielin Swenor, Lisa I. Iezzoni, and Steven Barnett NIH advances landmark recommendations on disability inclusion and anti-ableism
Politics Rachel Cohrs A Democratic Senate improves the outlook for Biden health and science priorities, including key nominees
Special Report Jonathan Wosen STAT Plus: ‘The tipping point is coming’: Unprecedented exodus of young life scientists is shaking up academia
Pharmalot Ed Silverman STAT Plus: Lawmakers push NIH to disclose steps being taken to ensure clinical trial results are reported